Usability of End-to-End Encryption in E-Mail Communication.

This paper presents the results of a usability study focused on three end-to-end encryption technologies for securing e-mail traffic, namely PGP, S/MIME, and Pretty Easy Privacy (pEp). The findings of this study show that, despite of existing technology, users seldom apply them for securing e-mail communication. Moreover, this study helps to explain why users hesitate to employ encryption technology in their e-mail communication. For this usability study, we have combined two methods: 1) an online survey, 2) and user testing with 12 participants who were enrolled in tasks requiring e-mail encryption. We found that more than 60% of our study participants (in both methods) are unaware of the existence of encryption technologies and thus never tried to use one. We observed that above all, users 1) are overwhelmed with the management of public keys and 2) struggle with the setup of encryption technology in their e-mail software. Nonetheless, 66% of the participants consider secure e-mail communication as important or very important. Particularly, we found an even stronger concern about identity theft among e-mail users, as 78% of the participants want to make sure that no other person is able to write e-mail on their behalf.

Serologic and molecular profile of anti-HBc-positive blood bank donors in an area of low endemicity for HBV.

Hepatitis B virus (HBV) infection leaves serological markers that indicate prior contact with the virus or an occult infection. The aim of this study was to determine the profile of HBV markers of individuals from a region of low HBV endemicity excluded from blood donation due to the presence of total anti-HBc antibodies but who tested negative for HBV surface antigen (HBsAg). The profile of 244 subjects exclusively anti-total hepatitis B core (anti-total HBc) reactive was determined. Markers such as anti-HBsAg, HBeAg (HBV core antigen) and anti-HBe (antibody to hepatitis Be antigen) were determined, and HB viral DNA (HBV-DNA) was identified by PCR analysis. Overall, 85.7% of the subjects had an anti-HBs (hepatitis B surface antigen antibody) titer higher than 10 IU/L; 154 samples were negative for HBeAg and 66.5% were reactive for anti-HBe. All samples were negative for HBV-DNA (n = 241). We found a significant association between the anti-HBe and anti-HBs titers (P = 0.026). Most individuals from a low endemic area for HBV have shown anti-HBs titers that confer immunity against HBV, even though they were negative for HBV-DNA. In the light of a shortage of donated blood worldwide, we suggest that special measures should be considered that would facilitate the possible use of these rejected blood units in areas of low endemicity for HBV.